Transdermal delivery of cyclodextrin-solubilized curcumin

Drug Delivery and Translational Research

Volumn 3, Issue 3, 2013, Pages 272-285

  Ghanghoria, Raksha ^a   Kesharwani, Prashant ^a   Agashe, Hrushikesh Bharat ^a   Jain, N K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Curcumin; Hydroxy propyl cyclodextrin; Penetration enhancer; Phase solubility studies

Indexed keywords

CURCUMIN; CYCLODEXTRIN; PENETRATION ENHANCING AGENT;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; INFRARED SPECTROSCOPY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PAW EDEMA; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SKIN IRRITATION; SKIN PERMEABILITY; SPECTROPHOTOMETRY; X RAY DIFFRACTION;

EID: 84877805947     PISSN: 2190393X     EISSN: 21903948     Source Type: Journal    
DOI: 10.1007/s13346-012-0114-y     Document Type: Article

References (33)

1. Drakulic BJ, Juranic IO, Eric S, Zloh M. Role of complexes formation between drugs and penetration enhancers in transdermal delivery. Int J Pharm. 2008;363(1-2): 40-9.
2. Loftsson T, Masson M. Cyclodextrins in topical drug formulations: theory and practice. Int J Pharm. 2001;225(1-2): 15-30.
3. Lopez RFV, Collett JH, Bentley MVLB. Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone. Int J Pharm. 2000;200(1): 127-32.
4. Uekama K, Adachi H, Irie T, Yano T, Saita M, Noda K. Improved transdermal delivery of prostaglandin E1 through hairless mouse skin: combined use of carboxy methyl-ethyl-beta- cyclodextin and penetration enhancers. J Pharm Pharmacol. 1992;44(2): 119-21.
5. Yang W, Chow KT, Lang B, Wiederhold NP, Johnston KP, Williams 3rd RO. In vitro characterization and pharmacokinetics in mice following pulmonary delivery of itraconazole as cyclodextrin solubilized solution. Eur J Pharm Sci. 2010;39(5): 336-47.
6. Felton LA, Wiley CJ, Godwin DA. Influence of hydroxylpropyl- beta- cyclodextrin on the transdermal permeation and skin accumulation of oxybenzone. Drug Dev Ind Pharm. 2002;28(9): 1117-24.
7. Vitroria M, Bentley LB, Vianna RF, Wilson S, Collett JH. Characterization of the influence of some cyclodextrins on the stratum corneum from the hairless mouse. J Pharm Pharmacol. 1997;49(4): 397-402.
8. Doliwa A, Santoyo S, Ygartua P. Influence of Piroxicam: hydroxypropyl-beta-cyclodextrin complexation on the in vitro permeation and skin retention of Piroxicam. Skin Pharmacol Appl Skin Physiol. 2001;14: 97-107.
9. Dias MMR, Raghavan SL, Pellett MA, Hadgraft J. The effect of β-cyclodextrins on the permeation of diclofenac from supersaturated solutions. Int J Pharm. 2003;263(1-2): 173-81.
10. Babu RJ, Pandit JK. Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin. Int J Pharm. 2004;271(1-2): 155-65.
11. Maestrelli F, Gonzalez-Rodri{dotless}guez ML, Rabasco AM, Mura P. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery. Int J Pharm. 2006;312(1-2): 53-60.
12. Yang J, Wiley CJ, Godwin DA, Felton LA. Influence of hydroxypropyl-b-cyclodextrin on transdermal penetration and photostability of avobenzone. Eur J Pharm Biopharm. 2008;69(2): 605-12.
13. Rajewski RA, Stella VJ. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm Sci. 1996;85(11): 1142-69.
14. Klang V, Matsko N, Zimmermann AM, Vojnikovic E, Valenta C. Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions. Int J Pharm. 2010;393(1-2): 152-60.
15. Ungaro F, Giovino C, Catanzano O, Miro A, Mele A, Quaglia F, La Rotonda MI. Use of cyclodextrins as solubilizing agents for simvastatin: effect of hydroxypropyl-β-cyclodextrin on lactone/hydroxyacid aqueous equilibrium. Int J Pharm. 2011;404(1-2): 49-56.
16. Arora RB, Basu N, Kapoor V, Jain AP. Anti-inflammatory studies on Curcuma longa (turmeric). Ind J Med Res. 1971;59(8): 1289-95.
17. Sharma OP. Antioxidant activity of curcumin and related compounds. Biochem Pharmacol. 1976;25(15): 1811-2.
18. Deodhar SD, Sethi R, Srimal RC. Preliminary study on anti-rheumatic activity of curcumin (diferuloyl methane). Ind J Med Res. 1980;71: 632-4.
19. Cho YI, Choi HK. Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix. Int J Pharm. 1998;169: 95-104.
20. Higuchi T, Connors KA. Phase Solubility techniques. Adv Anal Chem Instrum. 1965;4: 117-210.
21. Jayaprakasha GK, Jagan Mohan RL, Sakariah KK. Improved HPLC method for the determination of curcumin, demethoxy curcumin and bisdemethoxy curcumin. J Agric Food Chem. 2002;50(13): 3668-72.
22. Benesi HA, Hildebrand JH. A spectrophotometric investigation of the interaction of Iodine with aromatic hydrocarbons. J Am Chem Soc. 1949;71(8): 2703-7.
23. Zhang GY, Wang HY, Tang B. Study on the supramolecular interaction of curcumin and beta-cyclodextrin by spectrophotometry and its analytical application. J Agric Food Chem. 2002;50(6): 1355-61.
24. Tenjarla S, Puranajoti P, Kosina R, Mandal T. Preparation, characterization and evaluation of Miconazole-cyclodextrin complexes for improved oral and topical delivery. J Pharm Sci. 1998;87(4): 425-9.
25. Indian Pharmacopoeia: Controller of Publication, Ministry of Health and Family Welfare, Govt. of India, New Delhi 1996.
26. Gondaliya DP, Pundarikakshudu K. Studies in formulation, characterization of transdermal permeation of nimesulide from aqueous and emulgel. Indian Drugs. 2002;39: 465-73.
27. Dubey V, Mishra D, Dutta T, Nahar M, Saraf DK, Jain NK. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Contr Rel. 2007;123(2): 148-54.
28. Draize JH, Woodward G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82: 377-90.
29. ICH Harmonised Tripartite Guideline, stability testing of new drug substances and products Q1A (R2), 2003.
30. Tiwari SB, Udupa N, Rao BSS, Puma D. Thermosensiitive liposomes and localized hyperthermia-an effective bimodality approach for tumour management. Int J Pharm. 2000;32: 214-20.
31. Krishna G, Hodrick WF, Lang W, Lin X, Karra S, Mao J, Almassian B. Pharmaceutical development and manufacturing of a parenteral formulation of a novel antitumor agent, VNP40101M. AAPS Pharm Sci Tech. 2001;2(3): E14.
32. Lachman L, Lieberman HA, Kanig JL, editors. The theory and practice of industrial pharmacy. 3rd ed. Bombay: Varghese Publishing House; 1991. p. 171.
33. Al-Marzouqi AH, Elwy HM, Shehadi I, Adem A. Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques. J Pharm Biomed Anal. 2009;49(2): 227-33.